Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Autosomal-Dominant Multiple Pterygium Syndrome Is Caused by Mutations in MYH3.

American journal of human genetics | 2015

Multiple pterygium syndrome (MPS) is a phenotypically and genetically heterogeneous group of rare Mendelian conditions characterized by multiple pterygia, scoliosis, and congenital contractures of the limbs. MPS typically segregates as an autosomal-recessive disorder, but rare instances of autosomal-dominant transmission have been reported. Whereas several mutations causing recessive MPS have been identified, the genetic basis of dominant MPS remains unknown. We identified four families affected by dominantly transmitted MPS characterized by pterygia, camptodactyly of the hands, vertebral fusions, and scoliosis. Exome sequencing identified predicted protein-altering mutations in embryonic myosin heavy chain (MYH3) in three families. MYH3 mutations underlie distal arthrogryposis types 1, 2A, and 2B, but all mutations reported to date occur in the head and neck domains. In contrast, two of the mutations found to cause MPS in this study occurred in the tail domain. The phenotypic overlap among persons with MPS, coupled with physical findings distinct from other conditions caused by mutations in MYH3, suggests that the developmental mechanism underlying MPS differs from that of other conditions and/or that certain functions of embryonic myosin might be perturbed by disruption of specific residues and/or domains. Moreover, the vertebral fusions in persons with MPS, coupled with evidence of MYH3 expression in bone, suggest that embryonic myosin plays a role in skeletal development.

Pubmed ID: 25957469 RIS Download

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NHGRI NIH HHS, United States
    Id: U54 HG006493
  • Agency: NICHD NIH HHS, United States
    Id: HD024064
  • Agency: NICHD NIH HHS, United States
    Id: P30 HD024064
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK056338
  • Agency: NICHD NIH HHS, United States
    Id: R01 HD048895
  • Agency: NHGRI NIH HHS, United States
    Id: UM1 HG006493
  • Agency: NIAMS NIH HHS, United States
    Id: R01 AR066124
  • Agency: NHGRI NIH HHS, United States
    Id: RC2 HG005608
  • Agency: NIGMS NIH HHS, United States
    Id: T32GM07526
  • Agency: NICHD NIH HHS, United States
    Id: 1R01HD048895
  • Agency: NHGRI NIH HHS, United States
    Id: 1RC2HG005608
  • Agency: NHGRI NIH HHS, United States
    Id: U54HG003273
  • Agency: NHGRI NIH HHS, United States
    Id: R00 HG004316
  • Agency: NICHD NIH HHS, United States
    Id: U54HD061221
  • Agency: NIGMS NIH HHS, United States
    Id: T32 GM007526
  • Agency: NICHD NIH HHS, United States
    Id: U54 HD083092
  • Agency: NICHD NIH HHS, United States
    Id: U54 HD061221
  • Agency: NHGRI NIH HHS, United States
    Id: U54 U54HG006542
  • Agency: NICHD NIH HHS, United States
    Id: P01HD070394
  • Agency: NHGRI NIH HHS, United States
    Id: U54 HG003273
  • Agency: NHGRI NIH HHS, United States
    Id: 5R000HG004316
  • Agency: NIAMS NIH HHS, United States
    Id: R01AR066124
  • Agency: NHGRI NIH HHS, United States
    Id: 1U54HG006493
  • Agency: NICHD NIH HHS, United States
    Id: P01 HD070394
  • Agency: NCATS NIH HHS, United States
    Id: UL1 TR001067

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


ExAc (tool)

RRID:SCR_004068

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on January 9, 2023. An aggregated data platform for genome sequencing data created by a coalition of investigators seeking to aggregate and harmonize exome sequencing data from a variety of large-scale sequencing projects, and to make summary data available for the wider scientific community. The data set provided on this website spans 61,486 unrelated individuals sequenced as part of various disease-specific and population genetic studies. They have removed individuals affected by severe pediatric disease, so this data set should serve as a useful reference set of allele frequencies for severe disease studies. All of the raw data from these projects have been reprocessed through the same pipeline, and jointly variant-called to increase consistency across projects. They ask that you not publish global (genome-wide) analyses of these data until after the ExAC flagship paper has been published, estimated to be in early 2015. If you''re uncertain which category your analyses fall into, please email them. The aggregation and release of summary data from the exomes collected by the Exome Aggregation Consortium has been approved by the Partners IRB (protocol 2013P001477, Genomic approaches to gene discovery in rare neuromuscular diseases).

View all literature mentions

UCSC Genome Browser (tool)

RRID:SCR_005780

Portal to interactively visualize genomic data. Provides reference sequences and working draft assemblies for collection of genomes and access to ENCODE and Neanderthal projects. Includes collection of vertebrate and model organism assemblies and annotations, along with suite of tools for viewing, analyzing and downloading data.

View all literature mentions

OMIM (tool)

RRID:SCR_006437

Online catalog of human genes and genetic disorders, for clinical features, phenotypes and genes. Collection of human genes and genetic phenotypes, focusing on relationship between phenotype and genotype. Referenced overviews in OMIM contain information on all known mendelian disorders and variety of related genes. It is updated daily, and entries contain copious links to other genetics resources.

View all literature mentions

NHLBI Exome Sequencing Project (ESP) (tool)

RRID:SCR_012761

The goal of the project is to discover novel genes and mechanisms contributing to heart, lung and blood disorders by pioneering the application of next-generation sequencing of the protein coding regions of the human genome across diverse, richly-phenotyped populations and to share these datasets and findings with the scientific community to extend and enrich the diagnosis, management and treatment of heart, lung and blood disorders. The groups participating and collaborating in the NHLBI GO ESP include: Seattle GO - University of Washington, Seattle, WA Broad GO - Broad Institute of MIT and Harvard, Cambridge, MA WHISP GO - Ohio State University Medical Center, Columbus, OH Lung GO - University of Washington, Seattle, WA WashU GO - Washington University, St. Louis, MO Heart GO - University of Virginia Health System, Charlottesville, VA ChargeS GO - University of Texas Health Sciences Center at Houston

View all literature mentions